Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)

NCT ID: NCT02088801

Last Updated: 2015-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

480 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this second phase of the multicenter study the investigators are going to evaluate the use of three different videolaryngoscopes in patients undergoing elective surgery requiring general anesthesia with intubation. The investigators are hypothesizing that these three videolaryngoscopes will succeed for intubation at first attempt in at least 90% of all cases using a difficult airway simulation with extrication collars. As the gold standard, a standard Macintosh blade is being used for comparison.

The study consists of 4 arms. Each arm includes 120 patients, sums up to a total of 480 patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Difficult Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Airtraq, blade without channel for tracheal tube

intubation

Group Type EXPERIMENTAL

Airtraq, blade without channel for tracheal tube intubation

Intervention Type DEVICE

Intubation

KingVision , blade without channel for tracheal tube

intubation

Group Type EXPERIMENTAL

KingVision , blade without channel for tracheal tube intubation

Intervention Type DEVICE

A.P. Advance, blade without channel for tracheal tube

intubation

Group Type EXPERIMENTAL

A.P. Advance, blade without channel for tracheal tube intubation

Intervention Type DEVICE

Macintosh

intubation

Group Type EXPERIMENTAL

Macintosh

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Airtraq, blade without channel for tracheal tube intubation

Intubation

Intervention Type DEVICE

KingVision , blade without channel for tracheal tube intubation

Intervention Type DEVICE

A.P. Advance, blade without channel for tracheal tube intubation

Intervention Type DEVICE

Macintosh

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Airtraq A.P. Advance KingVision Macintosh

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective surgery with general anesthesia requiring intubation
* \>18 years old
* ASA I-III

Exclusion Criteria

* known or presumed difficult airway
* risk of pulmonary aspiration
* refusing to participate
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Insel Gruppe AG, University Hospital Bern

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lorenz Theiler

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Greif, MD MME FERC

Role: STUDY_CHAIR

Insel Gruppe AG, University Hospital Bern

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bern University Hospital and University of Bern

Bern, Canton of Bern, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SWIVIT II

Identifier Type: -

Identifier Source: secondary_id

106/12_2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Awake Intubation V-MAC VS
NCT03742830 COMPLETED
ETI During Intubation
NCT02295618 COMPLETED NA